Article

Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches

2020-02-19

Abstract excerpt

The emergence of the 2019 novel coronavirus (COVID-19), for which there is no vaccine or any known effective treatment created a sense of urgency for novel drug discovery approaches. One of the most important COVID-19 protein targets is the 3C-like protease for which the crystal structure is known. Most of the immediate efforts are focused on drug repurposing of known clinically-approved drugs and virtual screenin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cb999fe0-acd9-5cde-8567-466a2f1485e1
DOI: 10.26434/chemrxiv.11829102.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest

Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning ApproachesDOI 10.26434/chemrxiv.11829102.v2Read

Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual RealitySemantic proximity Read

De Novo Design and Bioactivity Prediction of SARS-CoV-2 Main Protease Inhibitors Using ULMFitSemantic proximity Read

Machine intelligence design of 2019-nCoV drugsSemantic proximity Read

A Novel de novo Design Study of Potent SARS-CoV-2 Main Protease Inhibitors Based on Reinforcement Learning and Molecular DockingSemantic proximity Read

New Potential Drug Candidates Against SARS-CoV-2 Using Generative ModelSemantic proximity Read

GALILEO Generatively Expands Chemical Space and Achieves One-Shot Identification of a Library of Novel, Specific, Next Generation Broad-Spectrum Antiviral Compounds at High Hit RatesSemantic proximity Read

Pocket-based molecule generation with an SE(3)-equivariant language model leads to a potent and selective HPK1 inhibitor with <i>in vivo</i> efficacySemantic proximity Read

PandoraGAN: Generating antiviral peptides using Generative Adversarial NetworkSemantic proximity Read

De-novo generation of novel phenotypically active molecules for Chagas disease from biological signatures using AI-driven generative chemistrySemantic proximity Read

Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCovSemantic proximity Read